To include your compound in the COVID-19 Resource Center, submit it here.

KRX-101 Sulodexide: Phase II

In an international, dose-ranging Phase II trial in 223 Type I and

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE